Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test

European Journal of Pain

Volumn 7, Issue 2, 2003, Pages 131-137

  Berrino, Liberato ^a   Oliva, Patrizia ^a   Massimo, Francesco ^a   Aurilio, Caterina ^a   Maione, Sabatino ^a   Grella, Antonio ^a   Rossi, Francesco ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Formalin test; Intraperitoneal route; Mice; NMDA antagonists; Nociception

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ANTINOCICEPTIVE AGENT; DEXTROMETHORPHAN; DIZOCILPINE; FORMALDEHYDE; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BIOMECHANICS; BODY MOVEMENT; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENCY; HINDLIMB; INJECTION; LABORATORY TEST; LICKING; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; DEXTROMETHORPHAN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FORMALDEHYDE; INJECTIONS, INTRAPERITONEAL; KETAMINE; MALE; MEMANTINE; MICE; NOCICEPTORS; PAIN;

EID: 0037226868     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(02)00086-1     Document Type: Article

References (28)

1. Abbott FV, Franklin KB, Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995;60:91-102.
2. Bresink I, Danysz W, Parson CG, Mutschler E. Different binding affinities of NMDA receptor channel blockers in various brain regions - indication of NMDA receptor heterogeneity. Neuropharmacology 1995;34:533-40.
3. Coderre TJ, Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 1994a;59:345-52.
4. Coderre TJ, Van Empel I. The utility of excitatory amino acid. Pain 1994b;59:353-9.
5. Cuzwar SJ, Gasior M, Turski WA, Kleinrok Z. Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists. Eur J Pharmacol 1994;264:1103-6.
6. D'Amico M, Berrino L, Maione S, Filippelli A, De Novellis V, Rossi F. Endothelin-1 in periaqueductal gray area of mice induces analgesia via glutamatergic receptors. Pain 1996;65:205-9.
7. Davidson EM, Carlton SM. Intraplantar injection of dextrorphan, ketamine, or memantine attenuates formalin-induced behaviors. Brain Res 1998;785:136-42.
8. Eisenberg E, Vos BP, Strassman AM. The NMDA antagonist memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain 1993;54:301-7.
9. Finney DJ. In: Statistical Method in Biological Assay. London: Charles Griffin & Company Ltd; 1978. p. 80.
10. Ghelardini C, Galeotti N, Bartolini A. Caffeine induces central cholinergic analgesia. Naunyn Schmiedebergs Arch Pharmacol 1997;356:590-5.
11. Hudspith MJ. Glutamate: a role in normal brain function, anaesthesia, analgesia and CNS injury. Br J Anaesth 1997;78:731-47.
12. Hunter JC, Sing L. Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat. Neurosci Lett 1994;20(174):217-21.
13. Kristensen JD, Karlsten R, Gordh T, Berge OG. The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain 1994;56:59-67.
14. Lutfy K, Weber E. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, an NMDA receptor antagonist, in the formalin and rotarod tests in mice. Pharmacol Res 1998;37:295-302.
15. Maione S, Vitagliano S, Berrino L, Lampa E, Rossi F. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats. Neuropharmacology 1992;31:403-7.
16. Maione S, Marabese I, Oliva P, de Novellis V, Stella L, Rossi Fsca, Filippelli A, Rossi F. Periaqueductal gray matter glutamate and GABA decrease following subcutaneous formalin injection in rat. NeuroReport 1999;10:1043-5.
17. Maione S, Oliva P, Marabese I, Palazzo E, Rossi Fsca, Berrino L, Rossi F, Filippelli A. Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception. Pain 2000;85:183-9.
18. Mori H, Mishima M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995;34:1219-37.
19. Nasstrom J, Karlsson U, Post C. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol 1992;25(212):21-9.
20. Omote K, Kawamata T, Kawamata M, Namiki A. Formalin induced release of excitatory amino acid in the skin of the rat hindpaw. Brain Res 1998;787:161-4.
21. Omote K, Kawamata T, Kawamata M, Nakayama Y, Hazama K, Namiki A. Activation of peripheral NMDA-nitric oxide cascade in formalin test. Anesthesiology 2000;93:173-8.
22. Peat SJ, Bras P, Hanna MH. A double-blind comparison of epidural ketamine and diamorphine for postoperative analgesia. Anaesthesia 1989;44:555-8.
23. Rossi F, Maione S, Berrino L. Periaqueductal gray area and cardiovascular function. Pharmacol Res 1994;29:27-36.
24. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992;51:5-17.
25. Vaccarino AL, Chorney DA. Descending modulation of central neural plasticity in the formalin pain test. Brain Res 1994;12(666):104-8.
26. Vaccarino AL, Marek P, Kest B, Weber E, Keana JFW, Liebeskind JC. NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. Brain Res 1993;615:331-4.
27. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.
28. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992;77:757-63.